Skip to main content
LabGenomics. Co., Ltd. logo

LabGenomics. Co., Ltd. — Investor Relations & Filings

Ticker · 084650 ISIN · KR7084650001 KO Human health and social work activities
Open in API
Filings indexed 370 across all filing types
Latest filing 2025-02-20 AGM Information
Country KR South Korea
Listing KO 084650

About LabGenomics. Co., Ltd.

http://www.labgenomics.co.kr/

LabGenomics is a biotechnology company specializing in molecular diagnostics and genetic analysis. The company's core activities are structured around three primary areas: diagnostic services, Next-Generation Sequencing (NGS), and the development and manufacturing of in-vitro diagnostic (IVD) products. It provides a comprehensive range of services, including general diagnostics, sample analysis, prenatal malformation testing, and cancer genetic testing. In addition to services, LabGenomics develops and sells diagnostic kits and devices, with a focus on applications for infectious diseases. The company is actively engaged in research and development to create innovative biotechnology products and is pursuing a global expansion strategy, notably through the acquisition of CLIA-certified laboratories to enhance its service capabilities.

Recent filings

Filing Released Lang Actions
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for LabGenomics. It contains the meeting agenda, date, location, voting procedures, and detailed management reports (business overview, industry status, and board activities) required for shareholder review prior to the meeting. This is a standard proxy statement/information document provided to shareholders for an upcoming AGM.
2025-02-20 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy/Voting Rights) and contains detailed information regarding the upcoming 23rd Annual General Meeting (AGM) of LabGenomics. It includes the purpose of the meeting, agenda items (such as approval of financial statements), and instructions for shareholders to exercise their voting rights via proxy or electronic voting. This document is a standard proxy solicitation material sent to shareholders to request their votes for the meeting.
2025-02-20 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is a correction filing ('정정신고'). It details changes to previously reported stock option grants, including the number of recipients and the total number of shares. This type of disclosure regarding equity compensation and capital structure changes falls under the category of Regulatory Filings (RNS) as it is a specific corporate disclosure required by the financial authorities (Financial Services Commission/Korea Exchange) that does not fit into more specific categories like Director's Dealing or Share Issue.
2025-02-11 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees, including the number of shares, exercise price, and legal basis. This type of disclosure regarding capital structure changes and employee compensation via stock options falls under the category of Regulatory Filings (RNS) as it is a specific corporate disclosure required by the exchange.
2025-02-11 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (CB). It details the change in conversion price, the number of shares affected, and the underlying calculation methodology based on market price fluctuations. This type of disclosure is a standard capital structure update related to financing instruments, which falls under the 'Capital/Financing Update' category.
2025-01-20 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the change in shareholding percentage by a major shareholder (Korea Securities Finance Corp) in a listed company (LabGenomics). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-01-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.